zohman

87 POSTS 0 COMMENTS

Study finds significant association between low bilirubin levels and venous thromboembolism

A recent paper published by Hakan Duman (Recep Tayyip Erdoğan University, Rize, Turkey) and colleagues in the Journal of Vascular Surgery: Venous and Lymphatic...

One-year results of VERNACULAR trial show significant improvement in patency rate...

 Michael D Dake (Tucson, USA) presented results from the VERNACULAR trial, which was designed to assess the performance of the Venovo venous stent (BD) for the...

VIRTUS subanalysis identifies correlates to improved patient outcomes after venous stenting

 Mahmood Razavi (Orange, USA) reported new data from a subanalysis of the VIRTUS trial, which set out to investigate the safety and efficacy of...

The rise of CLaCS and aesthetic phlebology

Kasuo Miyake is a leader in Cryo-Laser and Cryo-Sclerotherapy (CLaCS) treatments for varicose veins. Based in Sāo Paulo, Brazil, Miyake heads the vein clinic...

Healogics brings vein ablation services to its Wound Care Centres

Healogics, a provider of advanced chronic wound care services in the USA, has announced they have added vein ablation to their in-house service offerings...

BD receives US FDA Approval for Venovo venous stent

BD has announced that the US Food and Drug Administration (FDA) has granted premarket approval for the Venovo venous stent, the first stent indicated...

NICE aortic guidelines debate prompts scrutiny of venous guidelines and evidence...

At the 2018 Vascular Societies’ Annual Scientific Meeting (VSASM; 27–29 November, Glasgow, UK), Bruce Campbell from Exeter Medical in Exeter, UK, who previously chaired...

Johann Chris Ragg

Johann Chris Ragg speaks to Venous News about the innovations he pioneered and the work that inspired his projects, as well as the challenges...

Venous News 9 – January 2019 US Edition

In this issue: New ATTRACT data show greater benefits of catheter-based therapy for iliofemoral DVT patients NICE aortic guidelines debate prompts scrutiny of venous...

Venous News 9 – January 2019

In this issue: New ATTRACT data show greater benefits of catheter-based therapy for iliofemoral DVT patients NICE aortic guidelines debate prompts scrutiny of venous...

Urgo Medical announces NICE recommendation of UrgoStart for diabetic and venous...

The UK's National Institute of Health and Care Excellence (NICE) has published new guidance recommending UrgoStart wound dressings (Urgo Medical) for treatment of diabetic...

Endpoints for first-in-human VenoValve study announced by Hancock Jaffe

Medical device company Hancock Jaffe has announced the end-points for its upcoming VenoValve first-in-human study in Bogota, Colombia. Endpoints for the study will include...

A need to clarify the role of compression in leg ulcer...

Speaking at the Leipzig Interventional Course (LINC; 22–25 January, Leipzig, Germany), Katja Mühlberg of the University of Leipzig, Germany, called for an improvement in...

VIRTUS 12-month outcomes presented at LINC: Vici stent meets primary endpoints

New 12-month data from the VIRTUS trial demonstrates that patients who were treated with the Vici Venous Stent system (Boston Scientific) for iliac and femoral...

Study found “excellent” long-term results for large, braided self-expanding stents in...

A single-centre experience using large, braided self-expanding stents for iliofemoral venous obstruction found "excellent" outcomes. Several useful techniques and pearls for improved outcomes are...

Merit Medical acquires assets of Vascular Insights

Merit Medical Systems, Inc. has announced that it has acquired substantially all of the assets of Vascular Insights, LLC, based in Quincy, USA. Vascular...

SeCure trial finds laser safe and effective in treating perforator veins,...

The study data were delivered in two presentations at VEITHsymposium (13–17 November, New York, USA) by Mark Adelman (NYU Langone Hosptial, New York, USA)...

American College of Phlebology adopts new name: American Vein and Lymphatic...

The members of the American College of Phlebology (ACP) have voted to change their name to the American Vein and Lymphatic Society (AVLS). The...

First patients enrolled in FLASH registry using the FlowTriever system for...

Inari Medical has announced the enrolment of the first patient in the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) using the company’s...

Rivaroxaban trial finds significant VTE reduction in cancer patients

Results from the Phase 3 CASSINI study contributes new data on the use of oral anticoagulant rivaroxaban (brand name Xarelto, Johnson & Johnson) in...

Venous News 8 – November US Issue

In this issue: Strategies needed to address radiation exposures during venous procedures Nationwide study finds no significant difference between rivaroxaban and apixaban for VTE...

Venous News 8 – November Issue

In this issue: Strategies needed to address radiation exposures during venous procedures Nationwide study finds no significant difference between rivaroxaban and apixaban for VTE...

Positive preliminary results from trial of first non-invasive approach to treat...

Theraclion has announced that Alfred Obermayer, principal investigator of the varicose vein treatment clinical trial in Austria, presented preliminary results at the Congress of...

Changing the narrative around light compression

At the Royal Society of Medicine (RSM) Venous Forum meeting (25–26 June, London, UK), Alison Hopkins was asked to speak about managing painful leg...

Nationwide study finds no significant differences between rivaroxaban and apixaban for...

A recent Danish study, examining a nationwide cohort of 8,187 patients with venous thromboembolism (VTE) treated with one of two new oral anticoagulant therapies,...

Strategies needed to address radiation exposure risks during venous procedures

Research presented at the European Society for Vascular Surgery’s annual meeting (ESVS; 25–28 September, Valencia, Spain) has shone a light on the potentially high...

Venous News 7 – September US issue

In this issue: "Crystal clear" evidence that higher compression reduces ulcer recurrence New intravascular ultrasound-based scoring system may predict stent failure Managing superficial vein...

Four-month follow-up for first procedures using blueflow Venous Stent

This article is an advertorial sponsored by plus medica The blueflow Venous Stent developed by plus medica GmbH & Co. KG received CE mark in...

Kathleen Gibson

An accomplished vascular surgeon and prominent clinical researcher in the venous field, Kathleen Gibson (Lake Washington Vascular Surgeons, Bellevue, USA) plays an active role...

Venous News 7 – September 2018

In this issue: "Crystal clear" evidence that higher compression reduces ulcer recurrence New intravascular ultrasound-based scoring system may predict stent failure Managing superficial vein...

AngioJet thrombectomy can reduce dose and duration of lysis compared to...

Anna Louise Pouncey revealed at the European Venous Forum annual meeting (EVF; 28–30 June, Athens, Greece) the findings of the GSTT venous team (Guy’s...

Current aspects in the management of superficial vein thrombosis

Superficial vein thrombosis is not a rare disease, with an incidence of 0.64 in 1,000 annually.1 The POST, OPTIMEV and STEPH studies have shown...

Combining VVSymQ and VCSS scores: A valid method to predict...

The utility of combining patient- and physician-reported scores to stratify disease severity and treatment rationale in patients with varicose veins has been highlighted in...

Surgery better than foam sclerotherapy in patients with isolated AASV varicosis...

One of the first randomised controlled trials comparing two therapeutic regimes—surgery and foam sclerotherapy—in patients with anterior accessory saphenous vein (AASV) varicosis, has found...

New intravascular ultrasound-based scoring system may predict future venous stent failure

To accompany the growing importance of intravascular ultrasound (IVUS) as an adjuvant diagnostic tool when treating deep venous disease, a study sought to create...

Medical research committee gives approval for first-in-man VenoValve study

Hancock Jaffe Laboratories, a company specialising in bioprosthetic medical devices for treating cardiac and vascular diseases, has received approval for the first-in-man testing of...

Early identification of patients at high risk for iliofemoral DVT needs...

According to Fedor Lurie (Jobst Vascular Institute, Toledo, USA), who presented at the European Venous Forum Annual Meeting (EVF; 28–30 June, Athens, Greece), patients...

Catheter pullback system aims to standardise and automate endovenous techniques

lso snakeback
A first prototype of a novel endovenous therapy technology (SnakeBack, LSO Medical) integrated with a laser ablation platform was revealed earlier this year at...

Boston Scientific announces agreement to acquire Veniti

Boston Scientific has signed an agreement to acquire Veniti, a privately-held company in Fremont, USA which developed and commercialised the Vici venous stent system for...

NexGen Medical Systems launches XCOIL large vessel thrombectomy system

NexGen Medical Systems, Inc., a US medical device company, has announced the successful completion of the first human use of their XCOIL large vessel (18mm)...

Edoxaban emerges as alternative to dalteparin for cancer-associated VTE

A new analysis has identified patient populations with cancer-associated venous thromboembolism (VTE) who could benefit from treatment with oral anticoagulant edoxaban, taken once daily. Daiichi...

Venous News 6 – June 2018 US Edition

Highlights: Landmark EVRA trial provides first Level 1 evidence for early venous ablation Ultrasound-guided foam sclerotherapy of small saphenous vein as effective as endovenous...

Venous News 6 – June 2018 EU Edition

Highlights: Landmark EVRA trial provides first Level 1 evidence for early venous ablation Ultrasound-guided foam sclerotherapy of small saphenous vein as effective as endovenous...

Study reports two- to threefold reduction of varicose veins in pregnant...

A new randomised controlled trial evaluated the preventative effect of compression stockings during pregnancy on the incidence of varicose veins as well as venous...

One-year results of ACCESS PTS study brings “hope” for post-thrombotic syndrome...

The one-year results of the ACCESS PTS trial have shown that EKOS therapy (BTG) statistically improves post-thrombotic syndrome scores and sequelae as well as...

Deep venous obstruction interventions: What is needed in 2018

Cees Wittens writes for Venous News about the current state of deep venous obstruction interventions, what we might expect in the near future, and...

Moving towards a paradigm shift for pelvic venous disorders with launch...

Treatment of patients with pelvic venous disorders is a “controversial topic,” Kathleen Gibson (Lake Washington Vascular Surgeons, Bellevue, USA) said at the Charing Cross...

Direct anticoagulant for pulmonary embolism associated with reduced hospital time and...

New data from the MERCURY PE study have shown that patients with low-risk pulmonary embolism who were treated with the direct oral anticoagulant rivaroxaban,...

Venous valve implanted in Canada as Venus Medtech enter North American...

St Paul's Hospital in Vancouver, Canada has successfully completed two implantations of the VenusP-Valve (Venous Medtech), a self-expanding pulmonary valve. This is the first appearance of...

Acelity acquires UK-based advanced wound care company Crawford Healthcare

Major global wound care company Acelity is acquiring Crawford Healthcare, a growing UK-based advanced wound care and dermatology company, along with all of its...

Changes to lumen shape may be more important than area in...

Data presented at the Charing Cross Symposium (24–27 April, London, UK) indicate that a rounder post-stent lumen shape has a positive correlation to 12-month...

Prospective clinical data on the FlowTriever system confirms excellent results in...

Inari Medical have announced the presentation of results from its FlowTriever Pulmonary Embolectomy (FLARE) clinical study that evaluated the safety and effectiveness of the...

CX audience rejects idea that ATTRACT has the final say on...

According to a debate at the Charing Cross Symposium (CX; 24–27 April, London, UK), the vast majority of CX delegates disagree with the view...

Reviewing five years of deep venous stenting: What comes next?

For many venous specialists, dedicated venous stents represent the future—and the promise of an ideal venous stent on the horizon is a central topic...

Ultrasound-guided foam sclerotherapy of small saphenous vein as effective as endovenous...

Preliminary data from the Fovelass trial, presented at the Charing Cross Symposium (24–27 April, London, UK) by Claudine Hamel-Desnos (Caen, France) show that at...

FDA approves venous indication for VASCADE closure system

Cardiva Medical, a vascular closure device company, today announced it has received approval from the US Food and Drug Administration (FDA) for an expanded...

RSM Venous Forum releases guidance for management of leg ulcers

The Royal Society of Medicine Venous Forum council has created a document that is intended to aid physicians when treating patients with leg ulcers. The document,...

Use of IVUS to optimise outcomes in venous stenting

Intravascular ultrasound (IVUS) imaging technology provides the current gold standard technique for detection and characterisation of venous disease, Erin Murphy writes. In this article,...

Inari Medical announces completion of US$27 million Series C financing

Venture-backed medical device company Inari Medical has announced the close of a Series C financing totaling US$27 million. The company plans to use the capital to...

Ten patients successfully treated with recently CE-marked venous stent

Medical device company Plus medica has announced that 10 patients have been treated with the company’s blueflow Venous Stent. The first cases were performed...

Handheld superficial perfusion imaging system gets CE mark

The handheld medical imaging system HyperView (HyperMed Imaging) has received CE mark, allowing for distribution in Europe. The system is designed to detect perfusion...

American College of Phlebology relocates to Chicago

Representation is essential in the constantly changing medical landscape that healthcare professionals are facing. The American College of Phlebology (ACP) has begun several new...

UIP audience votes against stenting as standard for deep vein obstruction

UIP 2018
The deep venous world is wrestling with the question: To stent or not to stent. While the availability of new specialised venous stents is...

First-in-man usage of blueflow venous stent

Following the announcement of receiving the CE mark in early 2018, ab medica has now reported the first-in man usage of its blueflow Venous...

Study sees 42% of patients without post-thrombotic syndrome misclassified with Villalta...

The common diagnosis of post-thrombotic syndrome (PTS) includes a history of deep venous thrombosis and a Villalta Scale score of four or above. However, a...

Istanbul wins bid to host UIP 2021

UIP2021
The International Union of Phlebology World Congress (UIP) will head to Turkey in 2021 after Istanbul successfully won the bid to be the host...

Venous News Charing Cross 2018 – US Edition

Highlights: CX presents comprehensive Venous Controversies programme UIP audience votes against stenting as standard for deep vein obstruction Setting the record straight: Clarifying the...

Venous News Charing Cross 2018 – EU Edition

Highlights: CX presents comprehensive Venous Controversies programme UIP audience votes against stenting as standard for deep vein obstruction Setting the record straight: Clarifying the...

Rick de Graaf: Venous stenting

Rick de Graaf speaks to Venous News about complications from venous stenting, including causes and best treatment approaches for reinterventions after stenting.

Setting the record straight: Clarifying the misconceptions of the ATTRACT trial

A special session during the pre-conference Day of Innovation and Science at the American Venous Forum annual meeting (AVF; 20–23 February, Tucson, USA) presented...

High lysis completeness “guarantees high success rates” of iliac vein stent...

A recent study on iliac vein stenting following catheter-directed thrombolysis for deep vein thrombosis (DVT) has shown that technical and clinical success  require high...

European College of Phlebology changes leadership in aim to develop recognition...

After five years, the board of the European College of Phlebology is changing, announced Eberhard Rabe (University of Bonn, Bonn, Germany) at the European...

Inotec AMD Limited appoints new CEO

Inotec AMD
UK-based Inotec AMD Limited has announced the appointment of Craig Kennedy as its new chief executive officer on 3 March 2018. Inotec AMD is a...

Non-thermal techniques for treatment of venous ulcers: Off-label use of cyanoacrylate...

At the American Venous Forum (AVF; 20–23 February, Tucson, USA), a session on venous leg ulcers turned to possible future treatment strategies as Kathleen...

One-year data from venous stent registry “promising”

Efficacy data from the Arnsberg Registry at 12 months are promising, with high primary patency rates for a dedicated venous stent. Presenting the data at...

Armando Mansilha

Armando Mansilha is professor of Angiology and Vascular Surgery, Faculty of Medicine at the University of Porto, Porto, Portugal. In this interview with Venous...

Early results of iliocaval reconstruction with stents for venous outflow obstruction...

“Endovascular reconstruction of the chronically obstructed iliocaval venous tract with stents is technically feasible, minimally invasive and has an acceptable safety rate, said James...

Published ATTRACT data call into question validity of the Villalta scale

ATTRACT trial
Following the publication of the ATTRACT trial in the New England Journal of Medicine (NEJM) in December 2017, Venous News spoke to experts in...

Venous News 4 – January 2018 US Edition

Highlights: Published ATTRACT data call into question validity of the Villalta scale Brave Dreams trial finds venoplasty “safe, but largely ineffective” for MS patients ...

Venous News 4 – January 2018

Highlights: Published ATTRACT data call into question validity of the Villalta scale Brave Dreams trial finds venoplasty “safe, but largely ineffective” for MS patients ...

VQI Varicose Vein Registry: A tool to help guide decision-making at...

VQI Registry
Members of the venous community have had a longstanding commitment to collecting and analysing the outcomes of venous procedures. The Vascular Quality Initiative (VQI)...

Phlebology world heads Down Under for UIP

UIP 2018
Venous specialists from around the globe will meet in Melbourne for the much anticipated 2018 World Congress of Phlebology (UIP; 4–8 February, Melbourne, Australia)...

Pressure monitoring may be required to ensure consistent compression during venous...

Compression therapy for venous ulcers requires accurate monitoring to ensure successful delivery and the desired compression dose. However, according to a study presented at...

FDA mini-sentinel assessment confirms safety and effectiveness of Xarelto (rivaroxaban) amidst...

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced findings from the US Food and Drug Administration's (FDA) mini-sentinel assessment, confirming the positive...

Cancer-associated VTE trial sees “lower rate of recurrent VTE with edoxaban...

Daiichi Sanyoko has announced the results from their Hokusai-VTE CANCER trial evaluating the direct oral anticoagulant edoxaban for treatment of venous thromboembolism (VTE) in...

UEMS adopts the new European training requirements in Phlebology

The European Board of Phlebology has announced that the European Union of Medical Specialists (UEMS) have adopted the European training requirements presented by Jean-Jérôme...

Study to measure shorter duration EKOS therapy for pulmonary embolism is...

KNOCOUT PE
Global specialist healthcare company BTG has highlighted the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how hospitals and patients...